Literature DB >> 7716397

Human infection with Gongylonema pulchrum: a case report.

T Jelinek1, T Löscher.   

Abstract

A 43 year old woman developed a painful tumor at the left buccal mucosa. Following local anti-inflammatory treatment a 35 mm long, living female adult worm of Gongylonema pulchrum was extracted from the affected side. No further treatment was needed and recovery was complete 5 days after extraction. Infection had occurred possibly 6 weeks before in Hungary with ingestion of contaminated water from an open draw well. Although commonly occurring as parasitic infection of domestic cattle and other vertebrates, gongylonemiasis is very rare in humans. Only 48 cases have been described in the literature since 1864. Life cycle and pathology of G. pulchrum are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7716397

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  4 in total

1.  Human Gongylonema pulchrum Infection: Esophageal Symptoms and Need for Prolonged Albendazole Therapy.

Authors:  Claudia R Libertin; Mohammed Reza; Joy H Peterson; Jason Lewis; D Jane Hata
Journal:  Am J Trop Med Hyg       Date:  2017-01-30       Impact factor: 2.345

2.  A survey of dung beetles infected with larval nematodes with particular note on Copris lunaris beetles as a vector for Gongylonema sp. in Iran.

Authors:  Gholamreza Mowlavi; Elmira Mikaeili; Iraj Mobedi; Eshratbeigom Kia; Lotfali Masoomi; Hassan Vatandoost
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

3.  First case of human gongylonemosis in France.

Authors:  Bernard Pesson; Christel Hersant; Jean-François Biehler; Ahmed Abou-Bacar; Julie Brunet; Alexander W Pfaff; Hubert Ferté; Ermanno Candolfi
Journal:  Parasite       Date:  2013-02-14       Impact factor: 3.000

4.  Comorbid early esophageal cancer and Gongylonema pulchrum infection: a case report.

Authors:  Qiaozhi Zhou; Yongqiu Wei; Huihong Zhai; Shaogang Li; Rui Xu; Peng Li
Journal:  BMC Gastroenterol       Date:  2021-07-31       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.